Epoetin and nephrogenic systemic fibrosis

Journal of the American Academy of Dermatology

Volumn 58, Issue 1, 2008, Pages 174-175

  Saab, Georges ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; GADOLINIUM; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CELL PROLIFERATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; HIGH RISK PATIENT; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; LETTER; NEPHRECTOMY; NEPHROGENIC FIBROSING DERMOPATHY; PATHOGENESIS; PRIORITY JOURNAL; WOUND HEALING;

ERYTHROPOIETIN, RECOMBINANT; FIBROSIS; HUMANS; KIDNEY TRANSPLANTATION; SKIN DISEASES;

EID: 37349041741     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.10.012     Document Type: Letter

References (6)

1. Deo A., Fogel M., and Cowper S.E. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol 2 (2007) 264-267
2. Goveia M., Chan B.P., and Patel P.R. Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis. J Am Acad Dermatol 57 (2007) 725-727
3. Haroon A., Amin K., Jiang X., and Arcasoy M.O. A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol 163 (2003) 993-1000
4. Boom H., Mallat M.J., de Fijter J.W., Zwinderman A.H., and Paul L.C. Delayed graft function influences renal function, but not survival. Kidney Int 58 (2000) 859-866
5. López-Gómez J.M., Pérez-Flores I., Jofré R., Carretero D., Rodríguez-Benitez P., Villaverde M., et al. Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance. J Am Soc Nephrol 15 (2004) 2494-2501
6. Marckmann P., Skov L., Rossen K., Heaf J.G., and Thomsen H.S. Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant 22 (2007) 3174-3178